Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study.
Désirée Mfm van der HeijdeLianne S GenslerWalter P MaksymowychRobert B M LandeweMartin RudwaleitLars BauerThomas KumkeMindy KimSimone Emanuele AuteriBengt HoepkenAtul A DeodharPublished in: RMD open (2022)
NCT02552212.